SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-165060
Filing Date
2009-08-05
Accepted
2009-08-05 13:12:56
Documents
7
Period of Report
2009-08-03
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 19451
2 FORM OF 6 MONTH WARRANT dex41.htm EX-4.1 75379
3 FORM OF 4 YEAR WARRANT dex42.htm EX-4.2 75996
4 SECURITIES PURCHASE AGREEMENT DATED AUGUST 3, 2009 dex101.htm EX-10.1 251226
5 PRESS RELEASE dex991.htm EX-99.1 7617
6 GRAPHIC g79738ex4_1004.jpg GRAPHIC 3201
7 GRAPHIC g79738ex4_2004.jpg GRAPHIC 3201
  Complete submission text file 0001193125-09-165060.txt   440346
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 09986508
SIC: 2836 Biological Products, (No Diagnostic Substances)